Home > Pfizer

Pfizer/BioNTech Seeks US FDA Approval for New COVID-19 Boosters for Children

Pfizer and its German partner BioNTech are asking the US Food and Drug Administration (FDA) to approve the new COVID-19 booster vaccine shots targeting the Omicron variant for school-age children. Pfizer and BioNTech submitted an application for emergency use authorization of their BA.4 and BA.5 focused bivalent vaccines for children

Read More

Pfizer Launched ‘An Accord for Healthier World’ to Improve Health Equity for People

Pfizer Inc., launched a new initiative called ‘An Accord for a Healthier World’. This initiative aims to provide all the patented, high-quality medicines, and vaccines of Pfizer available in the United States and European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. This initiative seeks to

Read More

Moderna Sued Pfizer, BioNTech over COVID-19 Vaccine Technology

Moderna said it is suing Pfizer and BioNTech for patent infringement linked to the development of the first COVID-19 vaccines. The biotech company based in the United States is alleging that mRNA technology, which Moderna developed before the COVID-19 pandemic, was copied. The lawsuit, which is seeking unspecified financial damages, was

Read More

Pfizer, BioNTech Seeks EUA from US FDA for Omicron Adapted COVID-19 Vaccine

Pfizer Inc. and BioNTech announced they have completed a submission to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron adapted bivalent COVID-19 vaccine for individuals over 12 years. This application follows guidance from the US FDA to include clinical

Read More

Pfizer and Valneva Begins Phase 3 Trial of Lyme Disease Vaccine

Pfizer Inc. and Valneva has announced the beginning of a Phase 3 clinical study of Vaccine Against Lyme for Outdoor Recreationists (VALOR), to investigate the safety, efficacy, and immunogenicity of the investigational Lyme disease vaccine candidate known as VLA15. Annaliesa Anderson, senior vice president and head of vaccine research and development

Read More